Addex Pharmaceuticals (ADDXF.PK) announced the extension of its research collaboration with Merck & Co., Inc. (MRK), through an affiliate, for an additional year. The collaboration is focused on developing positive allosteric modulators of the metabotropic glutamate receptor 4 for the treatment of Parkinson's disease and other undisclosed indications.
Addex will receive research funding from Merck in addition to the original financial terms, which include milestones and royalties.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.